Infection Control Market Size, Share to Reach A Valuation of USD 55.9 Billion By 2027

SHARE THIS ARTICLE

The global Infection Control market gathered revenue around USD 41.6 Billion in 2020 and market is set to grow USD 55.9 Billion by the end of 2027 and is estimated to expand at a modest CAGR of 4.9% during the prediction period 2021 to 2027. 

Overview of Infection Control Market Study

Infection Control market study conducted by Nova One Advisor is intended at helping stakeholders get a comprehensive overview of potential challenges and undiscovered opportunities. The report offers exclusive insights to help companies and their customers to make informed decision to sustain growth through the assessment period.

Get your Customized Research Report@ https://www.novaoneadvisor.com/report/customization/4421

Growth Factors:

Growth in the infection control market can largely be attributed to factors such as the high incidence of hospital-acquired infections; the increasing number of surgical procedures; the growing geriatric population and increasing incidence of chronic diseases; the growing focus on food sterilization and disinfection; technological advancements in sterilization equipment; and the increasing outsourcing of sterilization services among pharmaceutical companies, hospitals, and medical device manufacturers. The growing number of medical device and pharmaceutical companies in emerging economies, increasing use of E-beam sterilization, re-introduction of ethylene oxide sterilization, and outsourcing operations to emerging countries with an improving healthcare sector will also support the growth of the market in the coming years. Currently, with the surge in cases of COVID-19, there is an increasing focus on personal hygiene and increasing production of medical nonwovens and single-use products, such as face masks and gloves. This, in turn, is expected to propel market growth in the next two years.

On the other hand, concerns regarding the safety of reprocessed instruments are expected to limit market growth to some extent in the coming years. This, along with factors such as the high cost of endoscope reprocessing, limited reimbursement in developing countries, and end-user non-compliance with sterilization standards, may hamper the growth of the market.

Infection Control Market Dynamics

Driver:  High incidence of hospital-acquired infections (HAIs)

Hospital-acquired infections (HAIs) are nosocomial infections that occur during a patient’s stay at hospitals and related facilities and are not observed at the time of admission. They are a major cause of morbidity and mortality worldwide. These infections include central line-associated bloodstream infections, surgical-site infections, catheter-associated urinary tract infections, hospital-acquired pneumonia, ventilator-associated pneumonia, and Clostridium difficile infections. The most common bacteria associated with HAIs include C. difficile, MRSA, Klebsiella, E. coli, Enterococcus, and the Pseudomonas species. Using infected medical devices during diagnostic and therapeutic procedures is a major cause of HAIs. According to the CDC, up to 1.7 million hospitalized patients in the US annually acquire healthcare-associated infections (HCAIs) while being treated for other health issues, and more than 98,000 of these patients (one in 17) die due to HCAIs. 32% of all HAIs in the country are urinary tract infections, 22% are surgical-site infections, 15% are lung (pneumonia) infections, and 14% are bloodstream infections. This is expected to boost the demand for sterilization and disinfectant products. The incidence of HAIs is mainly dependent on the patient’s immune status, infection control practices, and the prevalence of various infectious agents in the healthcare facility. Other factors include longer hospital stays, immunosuppression, older age, and stays in intensive care units. Around 20% of such infections occur in ICUs. The major pathogens causing HAIs include C. difficile, Staphylococcus aureus, Klebsiella, and Escherichia coli. The outbreak of COVID-19 and the growing cases of community transmission infections identified in healthcare personnel (HCP) have led to the implementation of guidelines for infection control by various government bodies across the globe. Considering such developments, the demand for infection control practices such as the proper use of sterilization and disinfectant products is expected to increase in healthcare facilities across the globe in the coming years.

Restraint: Adverse effects of chemical disinfectants

Most of the chemical disinfectants currently available in the market have toxic properties. For example, sodium hypochlorite is an effective treatment against blood-borne pathogens but is also highly corrosive and a respiratory irritant, which makes it dangerous for cleaning personnel and building occupants and toxic when released into the environment. The improper use of these disinfectants can cause environmental hazards and be harmful to patients exposed to them. Disinfectants sold in the US need to be registered with the Environmental Protection Agency (EPA), which classifies these solutions as pesticides; they are regulated under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). There is no green certificate currently available for disinfectants in the market. Due to the growing end-user population demanding a greener solution, the use of disinfectants is becoming limited, with their use being restricted to limited non-critical items and in lower amounts. Manufacturers are now being forced to develop newer, greener alternatives that are less corrosive to the human eyes, such as butyl-free, pH-neutral quaternary, and hydrogen peroxide-based disinfectants. In line with this, in 2018, Clorox Healthcare launched the new Clorox Healthcare Versa-Sure Cleaner Disinfectant Wipes that are alcohol-free.

Opportunity: Increasing use of E-beam sterilization

Electron-beam irradiation, also called beta irradiation, is a technique used commonly to sterilize pharmaceutical packaging products and medical devices. It operates by directing a continuous flow of electrons through the articles being sterilized. It is generally used for low- to medium-density products but not a good fit for extremely dense materials. This sterilization has the advantage of providing quick-turn terminal sterilization with simple, clean, on/off technology. There is no carcinogenic gas/radioactive source needed, and there are no residuals, so the product can be immediately released for distribution. Due to the growing applications of E-beam and its increasing uptake among different end-user segments, the market for e-beam sterilization is expected to witness significant growth during the forecast period. E-beam sterilization offers several advantages over other methods of sterilization. Using e-beam, products can be irradiated for only a few seconds and, therefore, may not be subject to radiation incompatibility, sometimes seen with gamma irradiation and ethylene oxide (EtO) sterilization. Moreover, the overall process time, inclusive of the transportation time, averages from five to seven minutes in this type of sterilization. Using established and recognized dosimetric release procedures, products can be released from quarantine as sterile within 30 minutes. While E-beam takes one minute per package for sterilization, gamma irradiation requires four to six hours, whereas EtO needs up to 14 days. Moreover, this technology can also be added to the production line. This helps in reducing distribution costs, the amount of handling, and related risks. Currently, 95% of all medical devices considered suitable for radiation sterilization can be sterilized using E-beam.

Challenge:  Development of alternative technologies for surface disinfection

Many new technologies are being developed and tested as an alternative to the current methods of surface disinfection, which are manual in nature. These include:

  • Electrolyzed water (Hypochlorous acid)
  • Cold atmospheric pressure plasma
  • Self-disinfecting surfaces
  • No-touch decontamination such as aerosol, vaporized hydrogen peroxide, and pulsed xenon UV light systems
  • Cold air atmospheric plasma

These technologies are in different stages of development and testing and show promising results. For example, in laboratory studies, the reactive oxygen species generated by cold air atmospheric systems have shown bactericidal activity against a variety of pathogens, with variable activity against C. difficile spores. One group of investigators found that electrolyzed water effectively reduced the number of aerobic bacteria (including staphylococci) on near-patient surfaces, but for reasons not well understood, it appeared to allow the regrowth of staphylococci within 24 hours of application. Electrolyzed water does not leave toxic residues on surfaces after its usage. Although commercializing such technologies will be challenging and cost-intensive, they do provide possible alternatives. In the coming years, post-commercialization, these technologies will pose a major challenge to the growth of traditional methods of surface disinfection, such as the use of liquids and sprays.

The protective barrier segment is expected to accounted for the largest share of the infection control market in 2020

Based on products & services, the market is further classified into cleaning & disinfection products, sterilization products & services, endoscope reprocessing products, protective barriers, and other infection control products. The protective barriers market accounted for the largest share of the infection control market in 2020. The large share of the protective barriers market can be attributed to the increasing adoption of medical nonwovens, such as face masks and surgical drapes & gowns, due to the current rise in COVID-19 cases.

The hospitals & clinics end-user segment is expected to account for the largest share of the infection control market

Based on end user, the infection control market is segmented into hospitals & clinics, medical device companies, pharmaceutical companies, life science industry, food industry, and other end users (cosmetic industry, dietary supplement manufacturers, the veterinary industry, and other healthcare providers such as long-term care facilities and diagnostic & imaging centers). The hospitals & clinics segment accounted for the largest share of the infection control market in 2020. The overall demand for infection control in hospitals is largely driven by the increasing prevalence of HAIs, the increasing number of hospitals and clinics worldwide, and the rising geriatric population (as this population segment is more susceptible to various chronic diseases). The growing volume of surgical procedures performed is also a major contributor to the growth of the infection control market for hospitals. The rising number of government initiatives to ensure high degree infection prevention is also a significant driver of the market segment.

North America is expected to account for the largest share of the infection control market in 2020

In 2020, North America accounted for the largest share of the infection control market, followed by Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The region’s large share can be attributed to the growing demand for and adoption of sterilization and disinfection products along with services as a result of the rising focus on healthy lifestyles and disease prevention among consumers. The surge in the geriatric population in the coming years and the subsequent increase in the prevalence of chronic diseases, the need for infection control to minimize the prevalence of HAIs, and implementation of favorable government initiatives and stringent regulations on sterilization and disinfection are also propelling the infection control market in the region.

Buy Complete Assessment of Infection Control market Now@ https://www.novaoneadvisor.com/report/checkout/4421

COVID-19 Impact on Infection Control Sales

Businesses today are operating in a dynamic environment. Earlier focus primarily concentrated on keeping pace with changing consumer preferences. COVID-19 outbreak was unprecedented and exposed vulnerabilities of various industries. Pandemic-induces obstacles also were registered in the Infection Control market.

Sales plummeted as COVID-19 gradually tightened its noose worldwide. Supply-chain disruptions caused massive losses, while demand took nose-dive as consumers remained indoors with affected countries implementing either partial or complete lockdown.

Gradual recovery however is on the cards with the roll out of vaccinations. Nonetheless, consecutive waves of the virus compelled businesses to stay prepared for the worst. As government and healthcare organizations successfully implement steps to contain the spread of COVID-19, industries have begun operations, albeit at a slow and more cautious pace.

Against this backdrop, Nova one advisor’s study predicts gradual recovery for the Infection Control market 2021 onwards. This trend will however continue through the course of the report’s assessment period

Key Players:

This report provides detailed company profiles of the key market players. This research report also highlights the competitive landscape of the Infection Control market and ranks noticeable companies as per their occurrence in diverse regions across globe and crucial developments initiated by them in the market space. This research study also tracks and evaluates competitive developments, such as collaborations, partnerships, and agreements, mergers and acquisitions; novel product introductions and developments, promotion strategies and Research and Development (R&D) activities in the marketplace. The competitive profiling of these players includes business and financial overview, gross margin, production, sales, and recent developments which can aid in assessing competition in the market.

Some of the prominent players in the Infection Control market include:

STERIS plc. (US),Getinge AB (Sweden), Cantel Medical Corporation (US), Advanced Sterilization Products (US), 3M Company (US), Belimed AG (Switzerland), MMM Group (Germany), MATACHANA GROUP (Spain), Sotera Health LLC (US), Ecolab, Inc. (US), Metrex Research Corporation (US), Reckitt Benckiser Group Plc. (UK), Miele Group (Germany), Melag (Germany), and Pal International (UK).

Unravelling the Critical Segments

This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:

Global Infection Control Market, by Product & Service

  • Sterilization Products and Services
    • Sterilization Equipment
      • Heat Sterilization Equipment
        • Moist Heat Sterilizers
        • Dry Heat Sterilizers
      • Low-Temperature Sterilization
        • Hydrogen Peroxide Sterilization
        • Ethylene Oxide Sterilization (ETO)
        • Formaldehyde Sterilization
        • Other Low-Temperature Sterilization
      • Radiation Sterilization
      • Filtration Sterilization
      • Other Equipment
    • Contract Sterilization Services Market
      • ETO Sterilization Services
      • Gamma Sterilization Services
      • E-Beam Sterilization Services
      • Steam Sterilization Services
      • Other Sterilization Services
    • Consumables and Accessories;
      • Sterilization Indicators
        • Chemical Indicators
        • Biological Indicators
      • Packaging Accessories
  • Cleaning and Disinfection Products
    • Disinfectants
      • Disinfectants, By Product Type
        • Hand Disinfectants
        • Surface Disinfectants
        • Skin Disinfectants
        • Instrument Disinfectants
      • Disinfectants, By Formulation
        • Disinfectant Wipes
        • Liquid Disinfectants
        • Disinfectant Sprays
      • Disinfectants, By EPA Classification
        • Low-Level Disinfectants
        • Intermediate-Level Disinfectants
        • High-Level Disinfectants
    • Cleaning and Disinfection Equipment
      • Washer Disinfectors
      • Flusher Disinfectors
      • UV-Ray Disinfectors
      • Ultrasonic Cleaners
      • Other Cleaning and Disinfection Equipment
    • Lubricants and Cleaning Solutions
    • Disinfection and Cleaning Accessories
  • Protective Barriers
    • Medical Nonwovens
      • Surgical Drapes
      • Surgical Gowns
      • Face Masks
    • Covers and Closures
    • Goggles
    • Gloves
  • Endoscope Reprocessing Products
    • Endoscope Reprocessing Consumables
    • Endoscope Reprocessing Equipment
      • Automated Endoscope Reprocessors
      • Endoscope Tracking Systems
    • Other Endoscope Reprocessing Products
  • Other Infection Control Products

Global Infection Control Market, by End User

  • Hospitals & Clinics
  • Medical Device Companies
  • Pharmaceutical Companies
  • Life Science Industry
  • Food Industry
  • Other End Users

Browse Complete Table of Content@ https://www.novaoneadvisor.com/toc/infection-control-market

Why Buy this Report?

The purpose of Nova one advisor’s Infection Control market study is to provide stakeholders with a detailed picture of potential barriers and untapped opportunities. The report contains exclusive information to assist businesses in making informed decisions about how to maintain growth throughout the assessment period.

Download This Full Research Report, Click Here@ https://www.novaoneadvisor.com/report/checkout/4421

About Us

Nova One Advisor is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Nova One Advisor has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@novaoneadvisor.com

Web: https://www.novaoneadvisor.com/

James Root

James Root have over 6+ years of experience working in business development, and customer retention. I’ve gained my experience through serving higher education, healthcare, automotive, aerospace, manufacturing, local government and hospitality businesses with technical solutions.

View all posts by James Root →

Leave a Reply

Your email address will not be published. Required fields are marked *